Virpax Pharmaceuticals

Virpax Pharmaceuticals is a preclinical-stage company in Berwyn developing drug-delivery technologies aimed at non-opioid, non-addictive pain management and CNS disorders. Its pipeline includes a topical spray-film for osteoarthritis pain, an injectable liposomal local anesthetic for post-operative pain, and an intranasal peptide product targeting the brain. As a small preclinical company it funds operations largely through public stock offerings. It positions itself around the national push for opioid-alternative pain therapies.